The Steven Coutre Review of the 68th Annual American Society of Hematology Meeting

OverviewThe Steven Coutre Review of the 68th Annual American Society of Hematology Meeting offers an in-depth exploration of the groundbreaking research and emerging data on hematologic disorders presented at the 68th ASH conference. Participants will gain access to the latest treatment algorithms and strategies to optimize patient care. The review will utilize a variety of learning modalities, including case studies, panel discussions, and interactive audience response questions, fostering dynamic exchanges between expert faculty and attendees. This event will highlight significant advances in hematology, showcasing innovations in diagnosis and treatment that can be directly applied in clinical practice.

Registration
Early Bird Rates • Physicians/Nurses: $199• Non-Industry Allied Health Professionals : $199
Industry: $649• Residents/Fellows/Trainees - email Amanda Harrison ([email protected] Regular Rates as of 12/7/26: • Physicians/Nurses: $249• Non-Industry Allied Health Professionals: $249
Industry: $749 Room block available on a first-come, first-served basis. Click the location tab for more details!

CreditsAMA PRA Category 1 Credits™ (8.00 hours), Non-Physician Participation Credit (8.00 hours)

Target AudienceSpecialties - HematologyProfessions - Fellow/Resident, Non-Physician, Physician ObjectivesAt the conclusion of this activity, learners should be able to:
1. Implement the use of new chemotherapeutics and biologics in subpopulations of acute myeloid leukemia patients based on patient clinical and genetic profiles
2. Review new drug approvals and practical considerations for their safe and optimal use
3. Evaluate optimal sequencing and combinations of novel agents for CLL and lymphomas
4. Asses the role of new therapies in classical (non-malignant) hematology indications
5. Discuss available therapeutic options for patients with low- or high-risk myelodysplastic syndromes

AccreditationIn support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation
American Medical Association (AMA)
Stanford Medicine designates this Live Activity for a maximum of 8.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.